Navigating the regulatory landscape - enhancing spectroscopy validation and compliance in the pharmaceutical lab
FTIR spectroscopy is one of the most popular analytical techniques for QA/QC and materials identification in pharmaceutical laboratories. The speed, specificity, ease of use, and non-destructive nature of FTIR analysis make it attractive to big and small pharma as well as biotech firms. Analytical instrumentation used for these types of testing is required to be validated and comply with 21 CFR part 11 regulations.
In this webinar, you’ll learn about different types of analysis that can be carried out with FTIR spectrometers in pharmaceutical labs and what type of instrument qualifications are required. You’ll also learn about our spectroscopy and support solutions including FTIR, Near Infrared, Raman, and UV-Visible technologies.
Dr. Suja Sukumaran is a Product Manager at Thermo Fisher Scientific. She received her PhD in Biophysics from Johann Wolfgang Goethe University, Germany, as part of the international Max Planck research School and is the co-inventor of US PATENTS on ‘MspA Nanopores and related methods’ licensed to Illumina Inc. She is experienced and has expertise in molecular spectroscopy, visible and fluorescence imaging, and protein and lipid biochemistry. Her current research interests are AI for protein folding, microplastics, and recycling.